A woman with advanced ovarian cancer has become the first patient globally to receive a pioneering new therapy.
Tracy Tomlinson, 58, was given the experimental drug, ZI-MA4-1, at the Christie NHS Foundation Trust in Manchester.
A woman with advanced ovarian cancer has become the first patient globally to receive a pioneering new therapy.
Tracy Tomlinson, 58, was given the experimental drug, ZI-MA4-1, at the Christie NHS Foundation Trust in Manchester.